Related Experiment Video
Updated: Jun 23, 2025
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
31.9K
The Wiser Strategy of Using Beta-Agonists in Asthma: Mechanisms and Rationales.
Dong In Suh1,2,3, Sebastian L Johnston4
1National Heart and Lung Institute, Imperial College London, London, UK.
Allergy, Asthma & Immunology Research
|June 24, 2024
Summary
Beta-2 agonists relieve asthma symptoms but can increase inflammation. Combining them with inhaled corticosteroids (ICS) in one inhaler maximizes benefits and minimizes risks for asthma patients.
Area of Science:
- Pulmonology and Respiratory Medicine
- Pharmacology and Therapeutics
Background:
- Asthma guidelines have been revised due to safety concerns with beta-2 agonists.
- Beta-2 agonists provide bronchodilation but can induce pro-inflammatory mediators.
- Overuse or sole use of beta-agonists may worsen airway inflammation and asthma exacerbations.
Purpose of the Study:
- To evaluate the risks associated with beta-2 agonist use in asthma management.
- To propose an optimal strategy for integrating beta-2 agonists into asthma treatment regimens.
- To ensure the safe and effective use of beta-2 agonists while mitigating adverse effects.
Main Methods:
- Review of current asthma guidelines and scientific literature on beta-2 agonist safety.
- Analysis of the mechanisms by which beta-2 agonists induce inflammation.
- Evaluation of the protective role of inhaled corticosteroids (ICS) against adverse effects.
Main Results:
- Beta-2 agonists alone can worsen airway inflammation and exacerbate virus-induced inflammation.
- Inhaled corticosteroids (ICS) can prevent the pro-inflammatory effects of beta-2 agonists.
- Current guidelines suggest reserving short-acting beta-agonists for acute relief in ICS users.
Conclusions:
- Integrating beta-2 agonists with ICS, ideally in a combination inhaler, is an optimal strategy.
- This integrated approach maximizes bronchodilation benefits while preventing inflammatory side effects.
- Concurrent use ensures guideline compliance and enhances the safe, comprehensive management of asthma.
Related Concept Videos
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
246
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
246
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:17Drugs Used in Lower Respiratory Disorders: Overview
412
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
412
01:30Adrenergic Agonists: Therapeutic Uses
766
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
766
01:20Asthma: Pathogenesis and Management
384
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
384
01:24Antiasthma Drugs: Methylxanthines
216
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
216